1. Home
  2. PNFP vs MDGL Comparison

PNFP vs MDGL Comparison

Compare PNFP & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pinnacle Financial Partners Inc.

PNFP

Pinnacle Financial Partners Inc.

HOLD

Current Price

$98.49

Market Cap

13.3B

Sector

Finance

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$520.47

Market Cap

12.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNFP
MDGL
Founded
2000
2011
Country
United States
United States
Employees
3595
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
12.1B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
PNFP
MDGL
Price
$98.49
$520.47
Analyst Decision
Buy
Strong Buy
Analyst Count
16
12
Target Price
$111.20
$674.45
AVG Volume (30 Days)
1.2M
355.7K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
2.09%
N/A
EPS Growth
N/A
41.32
EPS
N/A
N/A
Revenue
N/A
$180,133,000.00
Revenue This Year
$160.52
$58.39
Revenue Next Year
$9.24
$48.55
P/E Ratio
$12.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$81.08
$265.00
52 Week High
$120.39
$615.00

Technical Indicators

Market Signals
Indicator
PNFP
MDGL
Relative Strength Index (RSI) 67.56 56.39
Support Level $92.97 $503.93
Resistance Level $101.94 $539.17
Average True Range (ATR) 2.44 16.69
MACD 0.89 -1.95
Stochastic Oscillator 91.58 38.54

Price Performance

Historical Comparison
PNFP
MDGL

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: